Entero Healthcare Q4 FY26 Earnings Preview Expectations Outlook

Fri Mar 20 2026

Entero Healthcare Solutions Q4 FY26 results date is all set to be announced soon and most investors are awaiting it. Professionals are expecting an increase in revenue due to higher sales and a significant rise in PAT. Entero Healthcare was listed on the National Stock Exchange (NSE) on 16-Feb-2024. Entero Healthcare Solutions share has its face value of 10 per share, and its NSE symbol is ENTERO. The company operates in the Healthcare sector and primarily belongs to the Pharma Distribution industry.

Table of Contents

Entero Healthcare Solutions Q4 Results 2026 Preview

Entero Healthcare Solutions Q4 FY26 revenue is expected to be around High Growth, representing a 14% YoY increase compared to the same quarter last year.
Profit After Tax, or PAT, is projected to rise 16% YoY.
EBITDA to rise 14%.
Entero Healthcare Solutions is expected to show High Growth in its revenue.

Click and Sign Up to Get Live Updates on Q4 Results

Entero Healthcare Solutions Share Performance

Over the past six months, Entero Healthcare Solutions share price has Positive by 13% to 1,091.30.
Moreover, over the past year, the stock has Positive by 20%
Despite this weak short-term performance, Entero Healthcare Solutions stock has delivered a financially sound NA return over the past 5 years.
As of today, 18-03-2026, the Entero Healthcare Solutions share price is trading at 1,091.30 per share.

Key Factors to Watch for Entero Healthcare Solutions Q4 Results FY26

Revenue Growth & Segment Performance – Focus on topline growth in the Pharma Distribution industry within the Healthcare sector.
Occupancy Levels & Seat Expansion – Monitor operational expansion and capacity utilisation trends.
Profitability & Margin Trends – Track EBITDA and PAT margins to evaluate cost control and operating efficiency.
Order Book & New Client Wins – Watch for updates on new contracts, partnerships, and long-term deals.
Balance Sheet & Cash Flow Position – Review debt levels, working capital management, and operating cash flows for financial stability.

About Entero Healthcare Solutions

Entero Healthcare distributes pharmaceutical products.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Final Thoughts

Entero Healthcare Solutions is gear up to announce its Q4 FY26 results. Analysts expect 14% revenue growth, a 16% rise in PAT, and a 14% rise in EBITDA. Entero Healthcare Solutions focuses on revenue growth from order execution, margin improvement, a strong order book, and management.

Stay informed with Univest blogs to get real-time updates on Entero Healthcare Solutions Q4 results FY26.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.